Vivani Medical (NASDAQ: VANI) furnishes updated investor slide deck

Rhea-AI Filing Summary

Vivani Medical, Inc. filed a current report to furnish its latest corporate slide presentation to the investment community. The slide deck, dated September 9, 2025, is attached as Exhibit 99.1 and is also available in the Investors section of the company’s website.

The slides are provided under Regulation FD as investor information and are deemed “furnished,” not “filed,” which limits their use for certain securities law liability purposes. Vivani notes the slides speak only as of their date and expressly disclaims any obligation to update them.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001266806 00012668062025-09-092025-09-09

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 9, 2025

Vivani Medical, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-36747		02-0692322
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1350 S. Loop Road

Alameda, California 94502

(Address of principal executive offices, including zip code)

(415) 506-8462

(Telephone number, including area code, of agent for service)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		VANI		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure

Vivani Medical, Inc. (the “Company”) from time to time presents and/or distributes to the investment community at various industry and other conferences slide presentations to provide updates and summaries of its business. These slides are attached to this Current Report on Form 8-K as Exhibit 99.1 and are incorporated by reference herein. The Company is also posting to the “Investors” portion of its website a copy of its current corporate slide presentation. The slides speak as of the date of this Current Report on Form 8-K. While the Company may elect to update the slides in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, the Company specifically disclaims any obligation to do so.

The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act, whether made before or after the date hereof, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Corporate Slides as of September 9, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		VIVANI MEDICAL, INC.
Date: September 9, 2025	By:	/s/ Donald Dwyer
	Name:	Donald Dwyer
	Title:	Chief Business Officer

FAQ

What did Vivani Medical (VANI) disclose in this 8-K filing?

Vivani Medical furnished its current corporate slide presentation to investors via an 8-K. The slides, dated September 9, 2025, are attached as Exhibit 99.1 and posted on the company’s website to provide business updates and summaries to the investment community.

Where can investors find Vivani Medical’s latest corporate slides?

Investors can access Vivani Medical’s latest corporate slide presentation as Exhibit 99.1 to this 8-K. The company is also posting the same slide deck in the “Investors” section of its website for broader access to the investment community.

Are Vivani Medical’s investor slides considered filed with the SEC?

No, Vivani Medical’s investor slides are treated as “furnished,” not “filed,” under the Exchange Act. The company states information in Item 7.01 and Exhibit 99.1 is not deemed filed or incorporated into other securities filings unless expressly referenced.

As of what date are Vivani Medical’s corporate slides effective?

Vivani Medical’s corporate slide presentation is stated as of September 9, 2025. The company notes the slides speak only as of that date and it specifically disclaims any obligation to update them for subsequent events or circumstances.

What exhibit numbers are included in this Vivani Medical 8-K?

The 8-K includes Exhibit 99.1, which contains Vivani Medical’s corporate slides as of September 9, 2025. It also lists Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document for compliance and data tagging purposes.